2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO (BBOT)
NASDAQ
$9.07-$0.010 (-0.11%)
Price as of Aug 21, 2026 7:56 PM EDT- $728.0MMarket Cap
- 2.71%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO (BBOT)
$9.07-$0.010 (-0.11%)
BBOT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.08 | ||
Change | $0.00 (0.00%) | ||
Open | $9.19 | ||
High | $9.44 | ||
Low | $9.03 | ||
Previous Close | $9.08 | ||
Volume | 171,565 | ||
30-Day Average Volume | 261,743 | ||
1-Week Change | 0.22% | ||
1-Month Change | 4.13% | ||
1-Year Change | 2.71% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 80.2M | ||
Total Assets | $376.7M | ||
Market Cap | $728.0M | ||
Enterprise Value | $673.9M | ||
Period: QTR TTM FY | |||
Revenue | $3.6M | ||
Net Income | -$56.5M | ||
Free Cash Flow | -$44.4M | ||
EBIT | -$56.5M | ||
EBITDA | -$56.4M | ||
Net Working Capital | $190.7M | ||
EPS | -$705.20 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 190 | ||
P/B | 2 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue